Conferences
: [5705]
Collection home page
Conference papers, abstracts, posters, or presentations.
Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 5705
Preview | Issue Date | Title | Author(s) |
| 13-Nov-2024 | Impact of pay-for-performance incentives for stroke unit access on hospital costs and utilisation. | Grimley R.S.; Kim J.; Collyer T.A.; Andrew N.E.; Horton E.S.; Cadigan G.; Cadilhac D.A.; Dewey H.M. |
| 13-Nov-2024 | Demographic disparities in the incidence and case fatality of subarachnoid haemorrhage: an 18-year nationwide study from New Zealand. | Rautalin I.; Krishnamurthi R.V.; Anderson C.S.; Barber A.; Barker-Collo S.; Bennett D.; Boet R.; Correia J.A.; Douwes J.; Law A.; Nair B.; Thrift A.G. ; Ao B.T.; Tunnage B.; Ranta A.; Feigin V. |
| 13-Nov-2024 | Progress update on the phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of arg-007 in acute ischemic stroke patients (SEANCON). | Blacker D.J.; Thomas M.G.; Phillips T.; Donnan G.; Saver J.L.; Dallimore L.; South S.; Knuckey N.W.; Meloni B.P.; Ghia D.; Chemmanam T.; Cheung A.; Cordato D.; Levi C.; Ma H. ; Campbell B.; Wong A. ; Bailey P.; Kleinig T.; Hankey G.J. |
| 13-Nov-2024 | Novel vascular territory mapping algorithm as a predictive tool for identification of antegrade flow in MCA occlusion. | Valente M.; Parsons M.; Chen C. ; Visser M.; Ma H. ; Bivard A. |
| 13-Nov-2024 | Prehospital recruitment of ultra-early ICH patients in the STOP-MSU trial: implications for patient selection in ICH trials. | Zhao H.; Yassi N.; Wu T.; Churilov L.; Yogendrakumar V.; Ma H. ; Anderson D.; Campbell B.; Donnan G.; Davis S. |
| 13-Nov-2024 | Remote evaluation of pre-stroke driving, shopping, banking capability as an alternative to modified rankin for reperfusion decisions - results from a telestroke dataset. | Bladin C.; Kim J.; Bagot K.; Choi P.; Stewart D.; Frost T.; Cadilhac D. |
| 13-Nov-2024 | Movement-based mindfulness versus lifestyle education for managing physiological risk factors in stroke survivors: a phase II study. | Thayabaranathan T.; Paul M.; Walker R.; Hancock S.; Allan L.; Immink M.A.; Hillier S.; Kilkenny M.F.; Brodtmann A.; Gee E.; Carey L.; Stolwyk R. ; Bernhardt J.; Nilsson M.; Cadilhac D.A. |
| 13-Nov-2024 | Validation of CT perfusion based vascular territory mapping: correlation to visual pial grading and outcome measures. | Valente M.; Parsons M.; Yan B.; Chen C. ; Visser M.; Ma H. ; Bivard A. |
| 13-Nov-2024 | A study to determine stroke incidence, causes, treatments and outcomes for Aboriginal peoples of South Australia and the Northern Territory is feasible: a prospective population-based pilot study. | Dos Santos A.; Cheong E.; Balabanski A.; Goldsmith K.; Burrow J.; Brady S.; Alam F.; Parsons M.; Katzenellenbogen J.; Thrift A. ; Kleinig T.; Burchill L.; Brown A. |
| 13-Nov-2024 | Development of a comprehensive patient management platform for inpatient stroke care, including generation of Australian stroke clinical registry data reports. | Stewart D.; McTaggart M.; Arthurson L.; Choi P.; Bladin C. |
| 13-Nov-2024 | Reliability of questions about pre-stroke driving, shopping and banking as an alternative to the modified rankin scale for treatment decisions - results from a hospital dataset. | Frost T.; Kim J.; Bagot K.; Choi P.; Stewart D.; Cadilhac D.; Bladin C. |
| 13-Nov-2024 | Participant perceptions of the support after stroke with group-based classes (SASS) feasibility trial. | Purvis T.; Thayabaranathan T.; Immink M.A.; Hillier S.; Hancock S.; Brancatisano O.; Cadilhac D.A. |
| 13-Nov-2024 | A roadmap for research in post-stroke fatigue: consensus-based core recommendations from the third stroke recovery and rehabilitation roundtable. | English C.; Simpson D.; Billinger S.; Churilov L.; Coupland K.; Drummond A.; Kuppaswamy A.; Kutlubaev M.; Lerdal A.; Mahmood A.; Moseley L.; Pittman Q.; Riley E.; Sutherland B.; Wong C.; Corbett D.; Mead G. |
| 13-Nov-2024 | Beyond the protocol: navigating ethics and governance in the multisite QASC Australasia trial. | Dale S.; Fasugba O.; Coughlan K.; Saheb S.; McInnes E.; Cadilhac D.A.; Cheung N.W.; Hill K.; Page K.; Menendez E.S.; Neal E.; Pollnow V.; Slark J.; Ranta A.; Gilder E.; Levi C.; Grimshaw J.M.; Middleton S. |
| 13-Nov-2024 | Bridging borders for the use of evidence-based protocols for fever, hyperglycaemia (SUGAR) and swallow (FESS) and clinical practice: findings from a qualitative study of factors influencing their sustained use. | Coughlan K.; Fasugba O.; Dale S.; Hill K.; Cadilhac D.; Middleton S.; McInnes E.; McElduff B. |
| 19-Nov-2024 | Acute and short-term cardiac profile of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: prospective surveillance from the paediatric active enhance disease surveillance (PAEDS) network, Australia 2020-2023. | Varma S.; Wang N.; Hunter G.; Blyth C.; Finucane C.; Francis J.; Francis L.; Wong S.; Ayer J.; Wood N.; Britton P.; Carr J. |
| 19-Nov-2024 | COVID-19 MRNA vaccine associated myocarditis - 1 year follow-up from a tertiary children's hospital in Australia. | Varma S.K.; Carrigan L.; Ditchfield M.; Rao S. |
| - | The Jacana First 1000 Days clinic audit. “Three-Minute Thesis” | Kour, Rachel ; Kerr R.; Stevens, Penelope |
| - | Data informed n of 1 clinical trial design for ADHD symptoms in FASD. | Crichton, Ali ; Harris, Katrina ; Mcree J.; Nickles J; Anderson P.; Williams K. |
| - | Do N-of-1 trials provide the opportunity for high level evidence with potential for immediate impact for clinical care in children with FASD and ADHD | Crichton, Ali ; Harris, Katrina ; Mcree J.; Nickles J; Anderson P.; Williams K. |
Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 5705